Researchers at two California universities reviewed pivotal clinical trials done between 2017 and 2023. They found that only a small share of trials used to approve new drugs reflect the United States racial and ethnic makeup. Enrollment of Black and Hispanic people fell from 2021, while Asian participation rose and white participation stayed mainly steady.
The study notes many trials follow International Council for Harmonisation standards and take place in a few regions. It says much of Africa and large parts of Latin America are rarely included. The authors recommend setting diversity goals early, choosing testing locations to match local needs, and collecting biological samples to study drug responses.
Difficult words
- trial — a medical study to test a medicineclinical trials, trials
- enrollment — the act of people joining a study
- diversity — the presence of many different kinds of peoplediversity goals
- region — a large area of a country or worldregions
- sample — a small biological part taken for studybiological samples
- approve — to officially allow or accept something
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Related articles
Virtual diet and exercise program helps people with lymphoma
A study tested a virtual diet and exercise program for people getting chemotherapy for lymphoma. The program improved symptoms, attendance was high, and participants had better strength and physical performance during treatment.
Emory study: 2023–24 COVID vaccine gives lasting antibodies
Emory University measured antibody responses in 24 people after the 2023–24 monovalent vaccine targeting Omicron XBB.1.5. The study found long-lasting antibodies, cross-reactive protection with the ancestral WA1 strain, and a 2.8-fold boost from immune imprinting.
Nanoflowers help stem cells share mitochondria
Researchers at Texas A&M used microscopic "nanoflowers" to make stem cells produce more mitochondria and transfer them to aging or damaged cells, restoring energy and function without genetic changes or drugs.
New method builds synthetic phage genomes
Researchers developed a way to build complete bacteriophage genomes and edit single genes. The method addresses problems with hard-to-synthesize DNA and could speed matching phages for bacterial infection treatment.
Genes linked to chronic kidney disease
Researchers led by Alejandro Chade at the University of Missouri studied genes involved in chronic kidney disease using animal models. They found genes linked to kidney damage; silencing one gene lowered fibrosis. The team will map and test gene activity.
Coartem Baby: first malaria medicine for newborns
Swissmedic approved Coartem Baby in July 2025, the first antimalarial made for newborns under five kilograms. The tablet aims to close a long treatment gap in malaria-endemic parts of Sub-Saharan Africa.